Tezcan, Ezgi Akyıldız.Ekmekçi, Hakan.Özdemir, Gökhan.Gümüş, Haluk.Öztürk, Şerefnur.2020-03-262020-03-262019Tezcan, E. A., Ekmekçi, H., Özdemir, G., Gümüş, H., Öztürk, Ş. (2019). What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance?. Turkish Journal of Neurology, 25(3), 182-183.1301-062X1309-2545https://dx.doi.org/10.4274/tnd.galenos.2019.93206https://hdl.handle.net/20.500.12395/38389Multiple sclerosis (MS) is an autoimmune central nervous system disease characterized by inflammation, demyelination, and axonal damage (1). Ankylosing spondylitis (AS) is a common inflammatory rheumatic disease affecting the axial skeleton, which can cause structural and functional disorders and decreased quality of life, and cause a characteristic back pain and position (2). The coexistence of MS and AS is rare. Besides the neurogenetic and neuroepidemiologic aspects of this association, there may be an interactive interaction in the treatment. It may be necessary to examine the effect of this situation on the roadmap to be followed in the treatment of both diseases.en10.4274/tnd.galenos.2019.93206info:eu-repo/semantics/openAccessAnkylosing spondylitismultiple sclerosisdemyelinationArticle253182183#YOKQ4WOS:000487283000016N/A